1-Bromo-2-chloro-3,4,5-trifluorobenzene, 95.0%, 250mg

1-(Chloromethyl)-4-vinylbenzene, 500 ppm t-Butylcatechol inhibitor, 90.0%, 25g

Quinolin-7-ylmethanamine dihydrochloride, 97%, 100mg

4-Methyl-2-({[3-trifluoromethyl)phenyl]sulfonyl}amino)pentanoic acid, 96.0%, 1g

2-Hydrazino-5,7-dimethyl-1,3-benzothiazole, 95.0%, 250mg

{[4-(2-methylpropyl)phenyl]methyl}(propan-2-yl)amine hydrochloride, 95.0%, 10g

ETHYL 4-(3,3,3-TRIFLUOROPROP-1-YN-1-YL)BENZOATE, 95.0%, 250mg

Manganese powder, min. 99.6%, <100 mesh, 50 g, plastic packaging.

N-(Piperidin-4-yl)-6-(trifluoromethyl)pyridin-2-amine trihydrochloride, 1g

Pyrimidin-2-ylmethanol, 97.0%, 10g

Ethyl 2-(3-hydroxyoxetan-3-yl)acetate, 95.0%, 5g

9-IODOPHENANTHRENE, 97.0%, 25g

1-[(4-bromophenyl)sulfonyl]piperidine-2-carboxylic acid, 95.0%, 1g